Chris Benko is CEO and co-founder of Koneksa and has more than 25 years of experience in the pharmaceutical industry, including implementing the operating model for the translational medicine functions of Merck Research Labs. He has held executive roles across multiple corporate functions, including R&D and commercial, as well as leading global talent management. Chris launched Koneksa as an entrepreneur-in-residence with Merck’s corporate venture capital fund before establishing Koneksa as an independent company.